CASI Pharmaceuticals (CASIF) Return on Sales (2022 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Return on Sales came in at 0.11% in Q4 2025, down 10.0% YoY from 0.12% in Q4 2024, and down 209.54% on a QoQ basis from 0.03% in Q3 2025.
CASI Pharmaceuticals (CASIF) Return on Sales (2022 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 4 years of Return on Sales data on file, last reported at 0.11% in Q4 2025.
- Quarterly Return on Sales fell 10.0% year-over-year to 0.11% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.05% (down 4.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
- Return on Sales retreated to 0.11% in Q4 2025, from 0.03% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2022 to a low of 0.11% in Q4 2025.
- A 4-year average of 0.03% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales increased 8 bps — and 2025, when it decreased 10 bps.
- Tracing CASIF's Return on Sales over 4 years: stood at 0.1% in 2022, then climbed by 4 bps to 0.09% in 2023, then soared by 90 bps to 0.01% in 2024, then sank by 1002 bps to 0.11% in 2025.
- The last three Return on Sales figures came in at 0.11% (Q4 2025), 0.03% (Q3 2025), and 0.03% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |